Trial
NCT07527936
A Study of BEN301 Injection in theTreatment of Autoimmune Diseases
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
RenJi Hospital
Collaborators
—
Condition
Systemic Sclerosis (SSc)
Intervention
Single administration of 1x10^8 viable CD4+ CAR+ Foxp3+ cells.
Why stopped
company's decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04